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Introduction
Epidemiological studies have shown a significant relationship between the alcohol consumption and blood pressure (BP) [1] [2] [3] [4] [5] . It is conceivable that personal ability to metabolize ethanol (beverage alcohol) may modify such a relationship. The primary pathway of ethanol metabolism involves oxidation of ethanol to acetaldehyde, which is followed by oxidation to acetate catalyzed by aldehyde dehydrogenase-2 (ALDH2: NP 000681.2) [6] .
A nonsynonymous polymorphism, Glu504Lys (rs671), is known to have large influence on the ALDH2 activity [7] . This single nucleotide polymorphism (SNP) is frequently observed in Asians (∼50% of the Japanese possess the minor allele, 504Lys), whereas it is rare in the Caucasians [8, 9] .
The 504Lys allele, designated historically as ALDH2 * 2, results in the enzymatically inactive form of ALDH2 that fails to convert aldehyde into acetic acid rapidly. Accordingly, the concentration of serum acetaldehyde after alcohol intake reaches much higher levels in individuals with the ALDH2 * 2/ * 2 and ALDH2 * 2/ * 1 genotype when compared with homozygote of the wild type allele, ALDH2 * 1/ * 1 (19 and 6 times greater, resp.) [10, 11] . Since an elevated acetaldehyde level causes adverse reactions such as facial flushing, tachycardia, palpitations, and drowsiness in drinkers, even a small amount of alcohol consumption is often impossible for individuals with ALDH2 * 2/ * 2 [12, 13] . Considering these observations together, the ALDH2 genotype was implicated as a factor modifying the adverse effect of drinking on BP [14] [15] [16] . In fact, a recent genome-wide association study (GWAS) on Asian populations indicated that the genetic locus including the ALDH2 gene harbored a strong association with BP [17] . In this study, Kato et al. indicated that the ALDH2 * 2 allele associated with lower BP, which was highly dependent on drinking habit. Accordingly, in this communication, we attempted to obtain further evidence supporting this result in a longitudinal study as well as in a cross-sectional study using a population in Japan.
Materials and Methods

Subjects.
The study protocol was approved by the ethics committee of Shimane University School of Medicine and written informed consent was obtained from all participants.
Participants were recruited at health examinations held in Shimane prefecture from 2006 through 2012. In total, 3,202 participants were recruited. Measurements of height and weight were performed on site. Histories of smoking, alcohol consumption, diabetes mellitus, dyslipidemia, and medication were recorded at on-site interviews. Venous blood was collected after overnight fasting to measure biochemical parameters. Among those subjects, 560 received a health examination in 1986. This subgroup was used in a longitudinal assessment of the genetic effect of the ALDH2 polymorphism on BP over 20 years. This subgroup was named the "longitudinal cohort."
Blood Pressure Measurement.
BP was measured in a sitting position at all health examinations. Measurements were performed by certified nurses using an automatic sphygmomanometer, after allowing subjects at least 15-minute sedentary rest. An average of 3 measurements was obtained. Hypertension is defined as either systolic BP (SBP) ≥140 mm Hg and/or diastolic BP (DBP) ≥90 mm Hg, or taking antihypertensive medication.
Genotyping.
Genomic DNA was isolated from the peripheral blood samples. Genotyping of the Glu504Lys was performed by using the TaqMan method on a GeneAmp PCR 9700 machine (Thermo Fisher Scientific, Waltham, MA, USA) [18] . 
Results
The frequency of the ALDH2 genotypes in the studied population (0.61, 0.35, and 0.04 for * 1/ * 1, * 1/ * 2, or * 2/ * 2, resp.) was in agreement with those previously observed in the Japanese [7, 10] and was within the Hardy-Weinberg equilibrium.
Association between the ALDH2 polymorphism and BP was examined first in a cross-sectional analysis. Table 1 shows the demographic characteristics of the subjects. There was no significant difference between the two genotype groups in regard to gender composition, age, body mass index (BMI), and drinking habit. SBP and DBP were greater in ALDH2 * 1/ * 1 than the other genotypes although the genetic effect of the genotype on BP was attenuated when adjusted with drinking habit (see Table 1 ). Table 2 summarizes odds ratio of risk factors for hypertension calculated by the logistic regression analysis; the genotype of the Glu504Lys polymorphism was an independent risk factor for hypertension Disease Markers 3 We then examined the effect of the ALDH2 polymorphism on BP change in the longitudinal cohort. Table 3 shows the demographic characteristics of the subjects of the cohort. SBP was significantly elevated after 20 years of observation, whereas only a marginal change was found in DBP. Because elevation of SBP was significantly greater in women than in men, the following analysis was performed on both genders separately. In 2006, the number of habitual drinkers was reduced significantly compared to that in 1986. No significant effects of the ALDH2 genotype were identified either on the change in SBP or in DBP (Table 4) ; even analyses were performed separately on drinking habits in 1986 and/or 2006 (data not shown). Multivariate analysis indicated that only ΔBMI in men showed a significant association with ΔSBP (see Table S2 of the Supplementary Material available online at http://dx.doi.org/10.1155/2015/825435).
Discussion
The present study confirmed that the Glu504Lys polymorphism in the ALDH2 gene had a significant effect on BP under a cross-sectional study design.
A recent result of GWAS indicated that the Glu504Lys (rs671) was associated with BP in Asians including the Japanese [17] . According to this report, individuals carrying the G allele (ALDH2 * 1) showed significantly higher BP than those carrying the A allele (ALDH2 * 2). Of note, this association was largely influenced by drinking habit. This was observed also in our cross-sectional study. Habitual alcohol drinking has been demonstrated as a strong risk factor for hypertension [2, 3] . As individuals with ALDH2 * 1/ * 1 are expected to consume more alcohol than those with the other genotypes, most part of the association of the ALDH2 polymorphism with hypertension might be due to difference in alcohol intake. However, our subgroup analysis revealed that the ALDH2 polymorphism was a risk factor for hypertension even in nonhabitual drinkers (see Table  S1 ). This result implies that the ALDH2 genotype has an additional effect on BP independently of the alcohol intake. In addition to the dehydrogenase activity, ALDH shows a wide variety of biological activities, which related to oxidative stress, inflammation, and the serum level of asymmetric dimethylarginine (ADMA) [19] . However, it is unclear how the differences in genotypes of ALDH2 gene affect those activities that lead to the difference in blood pressure. Physiological and/or biochemical studies are essential to evaluate effects of the SNP on the metabolic pathway. In addition, a comprehensive genetic analysis in the ALDH2 locus may be necessary to identify polymorphisms responsible for this "alcohol-independent" effect because Glu504Lys may be a "passenger" polymorphism merely linked with the true responsible polymorphisms [17, 20] .
Although the association between the ALDH2 genotype and BP was confirmed in a cross-sectional analysis, it was not replicated in a longitudinal study. There are several possible reasons for this discrepancy; first of all, due to a small number of participants in the longitudinal study, the statistical power was not enough to show the effect of the ALDH2 genotype.
Second, age of participants in the longitudinal study was too high at the start of the study. In 1986, the mean age of participants was 51 years which was rather too old to study the development of hypertension longitudinally. Indeed, 319 of 560 individuals (56%) already had hypertension at that time. At this age, many of the participants harbored multiple risk factors for hypertension such as arteriosclerosis, even if they did not develop overt hypertension yet. This might have masked the effects of the genetic risk factors. Supporting this interpretation, age and drinking status, both of which are established risk factors for hypertension, failed to show a significant association with ΔSBP in the present longitudinal study. Further, menopause might be an additional disturbing factor on BP change among women [21, 22] ; most of the female subjects in the study were around the age of menopause in 1986, and they might show greater increase in BP during observational 20 years.
Third, in our study population, one-third of daily drinkers in 1986 quitted drinking during the following 20 years. Change in drinking habit might influence the genetic effect of the ALDH2 polymorphism.
In conclusion, we confirmed the effect of the Glu504Lys polymorphism in the ALDH2 gene on BP in a cross-sectional study, though we failed to show the association in a longitudinal analysis. Further studies using a large number of younger individuals are essential to obtain a conclusive result on the effect of the ALDH2 genotype on a longitudinal change of BP. 
